Skip to main content

Peer Review reports

From: Role of CDH23 as a prognostic biomarker and its relationship with immune infiltration in acute myeloid leukemia

Original Submission
15 Oct 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
5 Dec 2021 Reviewed Reviewer Report
8 Dec 2021 Reviewed Reviewer Report
30 Dec 2021 Author responded Author comments - Chunyan Ji
Resubmission - Version 3
30 Dec 2021 Submitted Manuscript version 3
12 Jan 2022 Author responded Author comments - Chunyan Ji
Resubmission - Version 4
12 Jan 2022 Submitted Manuscript version 4
30 Jan 2022 Reviewed Reviewer Report
31 Jan 2022 Reviewed Reviewer Report
15 Feb 2022 Author responded Author comments - Chunyan Ji
Resubmission - Version 5
15 Feb 2022 Submitted Manuscript version 5
19 Feb 2022 Author responded Author comments - Chunyan Ji
Resubmission - Version 6
19 Feb 2022 Submitted Manuscript version 6
17 Mar 2022 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
12 Apr 2022 Editorially accepted
21 May 2022 Article published 10.1186/s12885-022-09532-1

You can find further information about peer review here.

Back to article page